Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

MIXED(8)

DRUG(6)

OTHER(1)

DEVICE(1)

MK-3475

3 trials

not_applicablephase_2

aethlon-medical-inc, dan-zandberg

Continue PD-1/PD-L1 Inhibitors treatment

1 trial

phase_3

dan-zandberg

Phase II ARRY-614 + nivolumab

+7 more interventions

15 unique interventions5 categories

Analytics

Trial Phases

Phase 11

Phase 24

Phase 31

Trial Status

Completed3

Terminated1

Other2

Role Distribution

Principal Investigator6

PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT04453046Not ApplicableTerminated

Hemopurifier Plus Pembrolizumab in Head and Neck Cancer

Squamous Cell Carcinoma of the Head and Neck

PrincipalinvestigatorStart date: 2020-10-22

NCT04074967Phase 1/2Active Not Recruiting

Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab

Head and Neck Squamous Cell CarcinomaMelanomaNon-small Cell Lung Cancer+2 more

PrincipalinvestigatorStart date: 2020-06-11

NCT04080804Phase 2Active Not Recruiting

Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer

Head and Neck Squamous Cell Carcinoma (HNSCC)

PrincipalinvestigatorStart date: 2019-12-20

NCT04157985Phase 3Completed

Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors

Advanced Solid TumorsAnal CancerBladder Cancer+10 more

PrincipalinvestigatorStart date: 2019-11-15

NCT02777385Phase 2Completed

Pembrolizumab in Combination With Cisplatin and Intensity Modulated Radiotherapy (IMRT) in Head and Neck Cancer

Head and Neck Squamous Cell Carcinoma

PrincipalinvestigatorStart date: 2016-05-31

NCT02289209Phase 2Completed

Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck

Carcinoma, Squamous Cell of Head and NeckRecurrent Head and Neck Cancer

PrincipalinvestigatorStart date: 2016-03-09

Research Network

Collaboration Network

2 collaborators·1 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Squamous Cell Carcinoma of Head and Neck5 Melanoma2 Advanced Solid Tumors1 Anal Cancer1 Urinary Bladder Cancer1 Cancer of the Uterine Cervix1 Cholangiocarcinoma1 Colorectal Cancer1

Affiliations

UPMC Hillman Cancer Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Steven P. LaRosa, M.D.

Aethlon Medical Inc.

1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Worked with same sponsors:

Aethlon Medical Inc.

Collaborated on 1 trial

Similarity Score14%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

32 trials

Shared therapeutic areas:

MelanomaCarcinoma, Non-Small-Cell LungCancer of the Uterine Cervix+4 more

Similarity Score12%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

21 trials

Shared therapeutic areas:

Carcinoma, HepatocellularColorectal CancerCarcinoma, Non-Small-Cell Lung+3 more

Similarity Score10%

You Lu, MD

West China Hospital

18 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungNSCLCAdvanced Solid Tumors+2 more

Similarity Score8%

lin shen

Peking University Cancer Hospital & Institute

31 trials

Shared therapeutic areas:

Advanced Solid TumorsCancer of StomachColorectal Cancer+2 more

Similarity Score8%

E-mail: ClinicalTrials@ ImClone.com

Eli Lilly and Company

22 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungColorectal CancerAdvanced Solid Tumors+1 more

Worked with same sponsors:

Bristol-Myers Squibb

Similarity Score7%

Ajay Goel, PhD

City of Hope Medical Center

24 trials

Shared therapeutic areas:

Colorectal CancerCholangiocarcinomaCancer of Stomach+1 more

Similarity Score7%

Jeong Min Lee, MD

Seoul National University Hospital

34 trials

Shared therapeutic areas:

Carcinoma, HepatocellularCholangiocarcinomaColorectal Cancer

Similarity Score5%

Saleh K Saleh, MD

Minia University

23 trials

Shared therapeutic areas:

Carcinoma, HepatocellularCholangiocarcinomaColorectal Cancer

Similarity Score5%

Lin Shen, MD

Peking University Cancer Hospital & Institute

20 trials

Shared therapeutic areas:

Cancer of StomachColorectal CancerSolid Tumor

Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT04453046Not ApplicablePrincipalInvestigator

Hemopurifier Plus Pembrolizumab in Head and Neck Cancer

Squamous Cell Carcinoma of the Head and Neck

Terminated

NCT04074967Phase 1/2PrincipalInvestigator

Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab

Head and Neck Squamous Cell CarcinomaMelanomaNon-small Cell Lung Cancer+2 more

Active Not Recruiting

NCT04080804Phase 2PrincipalInvestigator

Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer

Head and Neck Squamous Cell Carcinoma (HNSCC)

Active Not Recruiting

NCT04157985Phase 3PrincipalInvestigator

Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors

Advanced Solid TumorsAnal CancerBladder Cancer+10 more

Completed

NCT02777385Phase 2PrincipalInvestigator

Pembrolizumab in Combination With Cisplatin and Intensity Modulated Radiotherapy (IMRT) in Head and Neck Cancer

Head and Neck Squamous Cell Carcinoma

Completed

NCT02289209Phase 2PrincipalInvestigator

Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck

Carcinoma, Squamous Cell of Head and NeckRecurrent Head and Neck Cancer

Completed

All 6 trials loaded